Gut Inflammation (60 Capsules) (Stable BPC-157 Arginate, KPV, Larazotide)

$235.00

& Free Shipping

Gut Inflammation is a research formulation containing stable BPC-157, KPV, palmitoylethanolamide (PEA), and tributyrin designed for studies on intestinal barrier function and inflammatory modulation. Each component contributes to signaling pathways related to epithelial regeneration, cytokine balance, and microbiome–host interaction. This blend is used in preclinical research investigating mucosal peptide regulation and enteric homeostasis mechanisms.

References:
Sikiric P et al., Curr Pharm Des, 2018 24(18):2002–2030
Getting SJ et al., J Immunol, 1999 163(10):5959–5967
Di Paola R et al., Mol Neurobiol, 2018 55(6):4785–4799

These capsules are provided exclusively as inert containers for the dry transport, storage, and handling of laboratory research materials. They are not dosage forms and are not intended for ingestion or administration. They must not be used as drug delivery systems, consumed, or administered in any form. For Research Use Only: Not for use in humans or animals. Not for diagnostic or therapeutic purposes.

 

Category:

What is this product?

“Gut Inflammation (60 Capsules)” is not a standardized medicine. It’s a proprietary “research blend” supplement-style product typically marketed for gut/immune pathways.

It usually combines peptides such as:

  • (Stable / arginate forms)
  • (Ac-KPV-NH2 anti-inflammatory peptide fragment)
  • (tight junction regulator used in celiac-related research)

These are often bundled into “gut repair stacks” in the peptide market.


What each ingredient is studied for

BPC-157

  • Studied for tissue repair and wound healing
  • Investigated in gut lining and inflammation models

KPV

  • Anti-inflammatory tripeptide fragment of α-MSH
  • Studied for immune and gut epithelial inflammation regulation

Larazotide

  • Tight junction modulator
  • Investigated in intestinal permeability (“leaky gut”) and celiac disease research

What “60 capsules” actually means

In listings like this:

  • Capsules are usually blended or pre-filled research formulations
  • Not standardized pharmaceutical dosing
  • Often labeled:

    “For research use only, not for human consumption” (clearcheck.ai)


Important reality check

Even though marketing makes it sound clinical:

  • ❌ Not FDA-approved
  • ❌ Not an approved digestive treatment
  • ❌ No validated oral dosing protocols for these peptide combinations
  • ✔ Classified as research chemical / experimental blend

And importantly: combining multiple experimental peptides does not automatically make a clinically proven therapy.


Why it’s popular

Search demand is driven by:

  • “Leaky gut” discussions
  • Inflammation and IBS-related communities
  • Biohacking / peptide stack trends
  • Online claims about gut lining repair

But most of the evidence for these compounds is preclinical or limited human research, not established clinical treatment use.


Key takeaway

This “Gut Inflammation (60 Capsules)” product is a commercial peptide blend built around experimental gut-inflammation–related molecules (BPC-157, KPV, Larazotide), but it is not an approved medication, and capsule blends like this are unregulated research formulations rather than standardized therapies.


gut inflammation (60 capsules) (stable bpc 157 arginate, kpv, larazotide)gut inflammation (60 capsules) (stable bpc 157 arginate, kpv, larazotide)gut inflammation (60 capsules) (stable bpc 157 arginate, kpv, larazotide)

Shopping Cart